Xilio Therapeutics, Inc.

NASDAQ:XLO

0.7 (USD) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 89.07355.29161.25974.94933.9844.70459.77275.38393.271120.385139.143159.41176.959198.05399.767120.299141.22219.238-48.845
Short Term Investments 00000000000000000097.69
Cash and Short Term Investments 89.07355.29161.25974.94933.9844.70459.77275.38393.271120.385139.143159.41176.959198.05399.767120.299141.22219.23848.845
Net Receivables 00003000000000000000
Inventory 0000000000000000000
Other Current Assets 4.1274.9432.053.0595.2053.4234.7083.0427.418.2226.3427.1948.2568.9285.8054.2871.41.3520
Total Current Assets 93.260.23463.30978.00869.18548.12764.4878.42593.271124.496142.314163.007181.087202.517105.572124.586142.62220.5948.845
Non-Current Assets:
Property, Plant & Equipment, Net 8.7289.0599.57410.00410.5411.20111.61312.16312.72912.8413.24213.23113.35313.59713.17313.44913.69913.6760
Goodwill 0000000000000000000
Intangible Assets 0000000000000000000
Goodwill and Intangible Assets 0000000000000-5.09200000
Long Term Investments 0001.7692.7631.5871.581.5741.5681.5621.5571.5541.5531.5531.5531.5531.55300
Tax Assets 00000000000003.53900000
Other Non-Current Assets 1.7881.7821.7750.0920.1210.0110.1690.1973.9370.2670.3010.3350.359-3.1460.4270.4360.472.051-48.845
Total Non-Current Assets 10.51610.84111.34911.86513.42412.79913.36213.93418.23414.66915.115.1215.26515.54315.15315.43815.72215.727-48.845
Total Assets 103.71671.07574.65889.87382.60960.92677.84292.359111.505139.165157.414178.127196.352218.06120.725140.024158.34436.3170
Liabilities & Equity:
Current Liabilities:
Account Payables 2.2752.5740.9721.2640.7461.051.4860.9452.0133.1251.811.412.3243.1443.8228.4092.6085.4440
Short Term Debt 1.2261.1881.1522.2321.0811.0472.0281.9627.6167.5856.7765.0493.3250.8011.5464.7464.0522.8970
Tax Payables 0000000000000000000
Deferred Revenue 40.25313.51826.10526.51721.72509.4047.1400012.08708.7518.1948.068013.7320
Other Current Liabilities 3.8839.9819.7938.6288.0313.8613.41513.3866.56510.4098.25611.3116.5768.8337.5038.159.63413.8140
Total Current Liabilities 47.63727.26138.02238.64131.58215.95716.92916.29316.19421.11916.84217.7712.22512.77812.87121.30516.29422.1550
Non-Current Liabilities:
Long Term Debt 6.6386.9547.2637.5667.86316.28416.838.68210.49312.35414.2116.05817.90619.73530.21216.00317.17118.320
Deferred Revenue Non-Current 38.74119.2628.39910.2517.39900000000-3.53900000
Deferred Tax Liabilities Non-Current 00000000000003.53900000
Other Non-Current Liabilities 00000-8.14200.0070.0260.0450.0640.0820.10.118214.097224.0251.12679.1290
Total Non-Current Liabilities 45.37926.21615.66217.81625.2628.1428.4158.68910.51912.39914.27416.1418.00619.853244.309240.02818.29797.4490
Total Liabilities 93.01653.47753.68456.45756.84424.09925.34424.98226.71333.51831.11633.9130.23132.631257.18261.33334.591119.6040
Equity:
Preferred Stock 00000000000000222.888222.888222.88878.00268.033
Common Stock 0.0050.0050.0040.0040.0030.0030.0030.0030.0030.0030.0030.0030.0030.00300.0010.00100
Retained Earnings -397.018-383.753-370.66-356.64-342.715-325.512-307.857-291.109-271.754-249.108-226.642-206.852-182.239-160.886-141.185-124.934-101.753-85.0860
Accumulated Other Comprehensive Income/Loss 0000000-00000000-222.889-0-0-29.523
Other Total Stockholders Equity 407.713401.346391.63390.052368.477362.336360.352358.483356.543354.752352.937351.066348.357346.3124.73-219.2632.617-76.2030
Total Shareholders Equity 10.717.59820.97433.41625.76536.82752.49867.37784.792105.647126.298144.217166.121185.429-136.455-121.309123.753-83.28738.51
Total Equity 10.717.59820.97433.41625.76536.82752.49867.37784.792105.647126.298144.217166.121185.429-136.455-121.309123.753-83.28738.51
Total Liabilities & Shareholders Equity 103.71671.07574.65889.87382.60960.92677.84292.359111.505139.165157.414178.127196.352218.06120.725140.024158.34436.31738.51